Heather R. Draper

Cape Town, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.

Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.

Journal: The Journal of infectious diseases

Published: March 20, 2026

Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries.

Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries.

Journal: IJTLD open

Published: May 08, 2025

Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countries.

Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countries.

Journal: IJTLD open

Published: May 05, 2025

Children's preferences among six novel moxifloxacin and linezolid-dispersible tablet formulations.

Children's preferences among six novel moxifloxacin and linezolid-dispersible tablet formulations.

Journal: IJTLD open

Published: October 29, 2024

Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis.

Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis.

Journal: British journal of clinical pharmacology

Published: September 24, 2024

Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis.

Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis.

Journal: British journal of clinical pharmacology

Published: September 24, 2024

Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis.

Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis.

Journal: The Journal of infectious diseases

Published: July 10, 2024

Linezolid Pharmacokinetic-Anemia Modeling in Children With Rifampicin-Resistant Tuberculosis.

Linezolid Pharmacokinetic-Anemia Modeling in Children With Rifampicin-Resistant Tuberculosis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 01, 2024

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.

Journal: The Lancet. Child & adolescent health

Published: April 26, 2024

Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis.

Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: December 19, 2023

Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis.

Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: November 16, 2023

Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment.

Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment.

Journal: IJTLD open

Published: September 26, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026